Cadus Reports First Quarter 2013 Results
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 05/13/13 -- (OTCBB: KDUS) announced today financial results for the first quarter ended March 31, 2013.
There were no revenues for the first quarter of 2013 and for the first quarter of 2012. Net loss for the first quarter of 2013 decreased to $139,555, compared to a net loss of $155,485 for the same period in 2012. The decrease in net loss can be principally attributed to a decrease in general and administrative expenses of $16,161, offset by a decrease in interest income of $98 and a decrease in income from other ventures of $133. Basic net loss per share for the first quarter of 2013 was $0.01, compared to basic net loss per share for the first quarter of 2012 of $0.01.
As of March 31, 2013, Cadus had 13,144,040 shares outstanding.
This press release may contain forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's annual report on Form 10-K for the year ended December 31, 2012. These include risks and uncertainties relating to the company's ability to license its technologies to third parties, the company's ability to acquire and operate other companies, the company's capital needs and uncertainty of future funding, the company's history of operating losses, the unpredictability of patent protection and the risk of obsolescence of the company's technologies.
David Blitz
212-575-7800
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.05.2013 - 11:39 Uhr
Sprache: Deutsch
News-ID 1226568
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 108 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cadus Reports First Quarter 2013 Results
"
steht unter der journalistisch-redaktionellen Verantwortung von
Cadus (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
